​

Funding Round

Series A - Vesalius Therapeutics

Series A - Vesalius Therapeutics

Investment Firm

Overview

Vesalius Therapeutics is focused on redefining the understanding and treatment of the diseases that drive ninety percent of human illness.

Announced Date

Mar 02, 2022

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Flagship Pioneering

Flagship Pioneering

Flagship Pioneering is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

1

Investor Name
Participant InvestorFlagship Pioneering

Round Details and Background

Vesalius Therapeutics raised $75000000 on 2022-03-02 in Series A

Vesalius Therapeutics is focused on redefining the understanding and treatment of the diseases that drive ninety percent of human illness.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 02, 2022
Series A - Vesalius Therapeutics
1-75.0M

Recent Activity

There is no recent news or activity for this profile.